Interpretable Multimodal Fusion Model Enhances Postoperative Recurrence Prediction in Gastric Cancer
Advanced Science · 2025-11 · 12 (43)
DOI: 10.1002/advs.202508190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 13.09.2025. Verfasst von Ping'an Ding und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050011, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Provincial Major Science and Technology Special Project.
Abstract (Originalsprache)
Accurate prediction of early postoperative recurrence in locally advanced gastric cancer (LAGC) remains challenging due to tumor heterogeneity and limitations of traditional clinicopathological factors. This study aims to develop and validate an interpretable multimodal model for precise recurrence prediction. 1580 LAGC patients are enrolled from six Chinese medical centers and a multimodal fusion Risk Stratification Assessment (RSA) model integrating clinical, radiomic, and pathomic data is developed. Model performance is evaluated using internal, external, prospective, and public dataset validations. Transcriptome sequencing is conducted to elucidate biological mechanisms underlying recurrence. The RSA model significantly outperforms clinical‐only, radiomic‐only, and pathomic‐only models in predicting early recurrence, achieving area under the curve (AUC) values of 0.903 in the training cohort, 0.902 in internal validation, and ranging from 0.884 to 0.889 in external validations. Stratification by the RSA model consistently identifies high‐risk patients with significantly poorer five‐year survival across all cohorts (all P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050011, China.
- Hebei Key Laboratory of Precision Diagnosis and Comprehensive Treatment of Gastric Cancer, Shijiazhuang, Hebei, 050011, China.
- Big data analysis and mining application for precise diagnosis and treatment of gastric cancer Hebei Provincial Engineering Research Center, Shijiazhuang, Hebei, 050011, China.
- Clinical College of Hebei University, Baoding, Hebei, 071000, China.
- The Department of CT/MRI, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050011, China.
- Department of Endoscopy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
ORCID-Profile: Qun Zhao
Förderung
- Hebei Provincial Major Science and Technology Special Project
Zitieren
APA
Ding, P., Yang, J., Chen, S., Guo, H., Wu, J., Wu, H., Yang, L., Ma, W., Tian, Y., Gu, R., Zhang, L., Meng, N., Li, X., Guo, Z., Liu, Y., Meng, L., & Zhao, Q. (2025). Interpretable Multimodal Fusion Model Enhances Postoperative Recurrence Prediction in Gastric Cancer. Advanced Science, 12(43). https://doi.org/10.1002/advs.202508190
Vancouver
Ding P, Yang J, Chen S, Guo H, Wu J, Wu H, et al. Interpretable Multimodal Fusion Model Enhances Postoperative Recurrence Prediction in Gastric Cancer. Advanced Science. 2025;12(43). doi:10.1002/advs.202508190
BibTeX
@article{Ding2025,
author = {Ding, Ping'an and Yang, Jiaxuan and Chen, Sheng and Guo, Honghai and Wu, Jiaxiang and Wu, Haotian and Yang, Li and Ma, Wenqian and Tian, Yuan and Gu, Renjun and Zhang, Lilong and Meng, Ning and Li, Xiaolong and Guo, Zhenjiang and Liu, Yueping and Meng, Lingjiao and Zhao, Qun},
title = {Interpretable Multimodal Fusion Model Enhances Postoperative Recurrence Prediction in Gastric Cancer},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {43},
doi = {10.1002/advs.202508190}
}
EUVIMED